MeiraGTx Holdings Plc (MGTX)
10.89
-0.16
(-1.45%)
USD |
NASDAQ |
Sep 25, 15:30
MeiraGTx Holdings Cash from Operations (TTM) : 13.69M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 13.69M |
| March 31, 2026 | 8.279M |
| December 31, 2025 | -46.36M |
| September 30, 2025 | -116.27M |
| June 30, 2025 | -129.07M |
| March 31, 2025 | -104.58M |
| December 31, 2024 | -104.50M |
| September 30, 2024 | -95.77M |
| June 30, 2024 | -95.16M |
| March 31, 2024 | -104.71M |
| December 31, 2023 | -105.36M |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | -38.00M |
| Date | Value |
|---|---|
| June 30, 2022 | -34.46M |
| March 31, 2022 | -27.91M |
| December 31, 2021 | -10.53M |
| September 30, 2021 | -58.92M |
| June 30, 2021 | -50.88M |
| March 31, 2021 | -42.50M |
| December 31, 2020 | -63.97M |
| September 30, 2020 | -56.38M |
| June 30, 2020 | -65.64M |
| March 31, 2020 | -74.50M |
| December 31, 2019 | 20.04M |
| September 30, 2019 | 30.55M |
| June 30, 2019 | 37.96M |
| March 31, 2019 | 40.67M |
| December 31, 2018 | -58.89M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Xencor, Inc. | -205.81M |
| UroGen Pharma Ltd. | -170.43M |
| Ironwood Pharmaceuticals, Inc. | 185.56M |
| Viking Therapeutics, Inc. | -418.44M |
| IDEAYA Biosciences, Inc. | -111.66M |